Home / Carbamazepine / Canada
CA ATC N03AF01 · updated 2 Nov 2026
Carbamazepine shortage in Canada
Is there a Carbamazepine shortage in Canada?
Yes. As of 2 Nov 2026, 2 Carbamazepine products are reported short in Canada, the first since 22 Oct 2014. The company estimate for the return is 20 Nov 2026. Main reason: other.
Also short in United States, Germany, Italy, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MAZEPINE (100) | BIOMED PHARMA | 22 Oct 2014 | not given | Other Other (Please describe in comments) |
| CA | TEGRETOL SUSPENSION (1 bottle of 450 mL) | NOVARTIS PHARMACEUTICALS CANADA INC | 25 Sep 2026 | 20 Nov 2026 | Increased demand Demand increase for the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.